Would IRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt?
IRhythm Technologies Analyst Ratings
Express News | IRhythm Technologies Inc : Citigroup Cuts Target Price to $110 From $135
Citi Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $110
IRhythm Technologies to Participate in Upcoming Investor Conferences in September
Wells Fargo Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $110
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and Irhythm Technologies (IRTC)
All You Need to Know About IRhythm Technologies (IRTC) Rating Upgrade to Buy
Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Oncolytics Biotech (ONCY) and Irhythm Technologies (IRTC)
Irhythm Technologies (IRTC) Receives a Buy From Wells Fargo
IRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing
IRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported Earnings, And Analysts Cut Their Target Price
IRhythm Technologies Second Quarter 2024 Earnings: Beats Expectations
IRhythm Technologies Price Target Cut to $100.00/Share From $133.00 by JP Morgan
IRhythm Technologies Is Maintained at Overweight by JP Morgan
Express News | IRhythm Technologies Shares Are Trading Lower After the Company Reported Q2 Financial Results. Also, Multiple Firms Lowered Their Respective Price Targets on the Stock
J.P. Morgan Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $100
IRhythm Technologies Is Maintained at Outperform by Baird
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $120
Oppenheimer Adjusts IRhythm Technologies Price Target to $145 From $165, Maintains Outperform Rating